Safety and Efficacy of BAY94-9027 in Previously Treated Male Children With Haemophilia A
NCT01775618
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
73
Enrollment
INDUSTRY
Sponsor class
Conditions
Hemophilia A
Interventions
BIOLOGICAL:
BAY94-9027
BIOLOGICAL:
BAY94-9027
BIOLOGICAL:
BAY94-9027
Sponsor
Bayer